Why in News ?
- Hyderabad-based Natco Pharma has recently received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market a generic Semaglutide injection in India.
- Earlier, the drug was extremely expensive and accessible only to a limited population.
- Generic availability may significantly transform diabetes and obesity management in India.

What is Semaglutide ?
Semaglutide is an anti-diabetic and anti-obesity medication belonging to the class of drugs called GLP-1 Receptor Agonists (GLP-1 RA).
What is GLP-1 ?
GLP-1 (Glucagon-Like Peptide-1) is a hormone released from the intestine after eating.
It helps regulate blood sugar, appetite, and metabolism.
Mechanism of Action
Semaglutide mimics the natural GLP-1 hormone in the body:
|
Action
|
Effect
|
|
Increases insulin secretion from pancreas
|
Lowers blood sugar
|
|
Suppresses glucagon
|
Reduces glucose production
|
|
Slows gastric emptying
|
Reduces hunger
|
|
Acts on brain appetite centers
|
Causes weight loss
|
Therefore, it is considered a metabolic disease drug, not just a sugar-control medicine.
Therapeutic Uses (Indications)
(A) Type-2 Diabetes
- Controls blood glucose
- Reduces insulin resistance
- Effective in long-term HbA1c reduction
(B) Cardiovascular Risk Reduction
In adults with diabetes + heart disease:
- Reduces heart attack risk
- Reduces stroke risk
- Lowers cardiovascular mortality
(C) Kidney Disease
In Type-2 diabetes with kidney involvement:
- Slows kidney failure progression
- Reduces death risk
(D) Obesity Treatment
WHO recognizes obesity as a chronic metabolic disease.
Semaglutide:
- Suppresses appetite
- Reduces calorie intake
- Produces 10–20% weight loss in clinical trials
Often called a “medical weight-loss revolution therapy.”
Global Significance
Semaglutide is termed a “weight-loss revolution drug” due to:
- Global obesity epidemic
- Rising diabetes burden
- Increasing lifestyle diseases
Importance for India
- India is often called the diabetes capital of the world (International Diabetes Federation estimates)
- Rising obesity & cardiovascular diseases make this drug highly relevant.
Available Forms
- Weekly injection
- Oral tablet (available in some countries)
Side Effects
|
Common
|
Serious (Rare)
|
|
Nausea, vomiting
|
Pancreatitis
|
|
Constipation
|
Gallbladder disease
|
|
Abdominal pain
|
Possible thyroid tumor risk (animal studies)
|
Importance for India
1. Generic Availability
Approval for Natco Pharma may:
- Reduce cost
- Improve middle-class access
- Enable public health program use
2. Role in NCD Control
Helps control:
- Diabetes
- Obesity
- Cardiovascular diseases
Challenges
- Not a substitute for lifestyle modification
- Long-term safety data still evolving
- Risk of misuse for cosmetic weight loss
- Dependence on expensive chronic therapy